Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NS101 phase 1b/2a study in healthy volunteers and sudden sensorineural hearing loss
KCT0009422Phase 2Completed
- Sponsor
- Neuracle Science
- Start
- Feb 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of NS101 in acute sensorineural hearing loss, sponsored by Neuracle Science. Started Feb 2024; status: completed.
02
Drugs
NS101
03
Conditions
acute sensorineural hearing loss
Beyond the preview
Go deeper on KCT0009422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0009422.